Method of treatment for reducing pulmonary inflammation in a patient with pathogen infection using oral prostacyclin analog drugs
A method of reducing mortality in a human patient with pulmonary inflammation due to coronavirus or other pathogen, the method including administering an oral dose of a prostacyclin analog drug to the patient within a therapeutic window. The prostacyclin analog drug includes oral iloprost or ilopros...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
20.07.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A method of reducing mortality in a human patient with pulmonary inflammation due to coronavirus or other pathogen, the method including administering an oral dose of a prostacyclin analog drug to the patient within a therapeutic window. The prostacyclin analog drug includes oral iloprost or iloprost betadex clathrate. |
---|---|
Bibliography: | Application Number: US202016847449 |